|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen J, Yao D, Li Y, Chen H, He C, Ding N,
Lu Y, Ou T, Zhao S, Li L and Long F: Serum microRNA expression
levels can predict lymph node metastasis in patients with
early-stage cervical squamous cell carcinoma. Int J Mol Med.
32:557–567. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nagamitsu Y, Nishi H, Sasaki T, Takaesu Y,
Terauchi F and Isaka K: Profiling analysis of circulating microRNA
expression in cervical cancer. Mol Clin Oncol. 5:189–194. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schiffman MH and Castle P: Epidemiologic
studies of a necessary causal risk factor: Human papillomavirus
infection and cervical neoplasia. J Natl Cancer Inst. 95:E22003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dueñas-Gonzalez A, Cetina L, Mariscal I
and de la Garza J: Modern management of locally advanced cervical
carcinoma. Cancer Treat Rev. 29:389–399. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Roque DR, Wysham WZ and Soper JT: The
surgical management of cervical cancer: An overview and literature
review. Obstet Gynecol Surv. 69:426–441. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang N, Wei H, Yin D, Lu Y, Zhang Y, Zhang
Q, Ma X and Zhang S: MicroRNA-195 inhibits proliferation of
cervical cancer cells by targeting cyclin D1a. Tumour Biol.
37:4711–4720. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rhoades MW, Reinhart BJ, Lim LP, Burge CB,
Bartel B and Bartel DP: Prediction of plant microRNA targets. Cell.
110:513–520. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lu Y, Zhou Y, Qu W, Deng M and Zhang C: A
Lasso regression model for the construction of microRNA-target
regulatory networks. Bioinformatics. 27:2406–2413. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Siomi H and Siomi MC: Posttranscriptional
regulation of microRNA biogenesis in animals. Mol Cell. 38:323–332.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gardiner AS, Twiss JL and
Perrone-Bizzozero NI: Competing interactions of RNA-binding
proteins, MicroRNAs, and their targets control neuronal development
and function. Biomolecules. 5:2903–2918. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Y, Guan DH, Bi RX, Xie J, Yang CH
and Jiang YH: Prognostic value of microRNAs in gastric cancer: A
meta-analysis. Oncotarget. 8:55489–55510. 2017.PubMed/NCBI
|
|
14
|
Drusco A and Croce CM: MicroRNAs and
cancer: A long story for short RNAs. Adv Cancer Res. 135:1–24.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Long MJ, Wu FX, Li P, Liu M, Li X and Tang
H: MicroRNA-10a targets CHL1 and promotes cell growth, migration
and invasion in human cervical cancer cells. Cancer Lett.
324:186–196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zou D, Zhou Q, Wang D, Guan L, Yuan L and
Li S: The downregulation of MicroRNA-10b and its role in cervical
cancer. Oncol Res. 24:99–108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang T, Zou P, Wang T, Xiang J, Cheng J,
Chen D and Zhou J: Down-regulation of miR-320 associated with
cancer progression and cell apoptosis via targeting Mcl-1 in
cervical cancer. Tumour Biol. 37:8931–8940. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ling S, Ruiqin M, Guohong Z, Bing S and
Yanshan C: Decreased microRNA-206 and its function in cervical
cancer. Eur J Gynaecol Oncol. 36:716–721. 2015.PubMed/NCBI
|
|
19
|
Chang KW, Liu CJ, Chu TH, Cheng HW, Hung
PS, Hu WY and Lin SC: Association between high miR-211 microRNA
expression and the poor prognosis of oral carcinoma. J Dent Res.
87:1063–1068. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cai K, Shen F, Cui JH, Yu Y and Pan HQ:
Expression of miR-221 in colon cancer correlates with prognosis.
Int J Clin Exp Med. 8:2794–2798. 2015.PubMed/NCBI
|
|
21
|
Cai C, Ashktorab H, Pang X, Zhao Y, Sha W,
Liu Y and Gu X: MicroRNA-211 expression promotes colorectal cancer
cell growth in vitro and in vivo by targeting tumor suppressor
CHD5. PLoS One. 7:e297502012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sakurai E, Maesawa C, Shibazaki M,
Yasuhira S, Oikawa H, Sato M, Tsunoda K, Ishikawa Y, Watanabe A,
Takahashi K, et al: Downregulation of microRNA-211 is involved in
expression of preferentially expressed antigen of melanoma in
melanoma cells. Int J Oncol. 39:665–672. 2011.PubMed/NCBI
|
|
25
|
Chu TH, Yang CC, Liu CJ, Lui MT, Lin SC
and Chang KW: miR-211 promotes the progression of head and neck
carcinomas by targeting TGFbetaRII. Cancer Lett. 337:115–124. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiang G, Cui Y, Yu X, Wu Z, Ding G and Cao
L: miR-211 suppresses hepatocellular carcinoma by downregulating
SATB2. Oncotarget. 6:9457–9466. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xia B, Yang S, Liu T and Lou G: miR-211
suppresses epithelial ovarian cancer proliferation and cell-cycle
progression by targeting Cyclin D1 and CDK6. Mol Cancer. 14:572015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma Y, Zheng X, Zhou J, Zhang Y and Chen K:
ZEB1 promotes the progression and metastasis of cervical squamous
cell carcinoma via the promotion of epithelial-mesenchymal
transition. Int J Clin Exp Pathol. 8:11258–11267. 2015.PubMed/NCBI
|
|
29
|
Chen Z, Li S, Huang K, Zhang Q, Wang J, Li
X, Hu T, Wang S, Yang R, Jia Y, et al: The nuclear protein
expression levels of SNAI1 and ZEB1 are involved in the progression
and lymph node metastasis of cervical cancer via the
epithelial-mesenchymal transition pathway. Hum Pathol.
44:2097–2105. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ran J, Lin DL, Wu RF, Chen QH, Huang HP,
Qiu NX and Quan S: ZEB1 promotes epithelial-mesenchymal transition
in cervical cancer metastasis. Fertil Steril. 103(1606–14): e1–2.
2015.PubMed/NCBI
|
|
31
|
Feenstra M, Veltkamp M, van Kuik J,
Wiertsema S, Slootweg P, van den Tweel J, de Weger R and Tilanus M:
HLA class I expression and chromosomal deletions at 6p and 15q in
head and neck squamous cell carcinomas. Tissue Antigens.
54:235–245. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Natrajan R, Louhelainen J, Williams S,
Laye J and Knowles MA: High-resolution deletion mapping of
15q13.2-q21.1 in transitional cell carcinoma of the bladder. Cancer
Res. 63:7657–7662. 2003.PubMed/NCBI
|
|
33
|
Lipton L and Tomlinson I: The genetics of
FAP and FAP-like syndromes. Fam Cancer. 5:221–226. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mazar J, DeYoung K, Khaitan D, Meister E,
Almodovar A, Goydos J, Ray A and Perera RJ: The regulation of
miRNA-211 expression and its role in melanoma cell invasiveness.
PLoS One. 5:e137792010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Maftouh M, Avan A, Funel N, Frampton AE,
Fiuji H, Pelliccioni S, Castellano L, Galla V, Peters GJ and
Giovannetti E: miR-211 modulates gemcitabine activity through
downregulation of ribonucleotide reductase and inhibits the
invasive behavior of pancreatic cancer cells. Nucleosides
Nucleotides Nucleic Acids. 33:384–393. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Song GQ and Zhao Y: MicroRNA-211, a direct
negative regulator of CDC25B expression, inhibits triple-negative
breast cancer cells' growth and migration. Tumour Biol.
36:5001–5009. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ye L, Wang H and Liu B: miR-211 promotes
non-small cell lung cancer proliferation by targeting SRCIN1.
Tumour Biol. 37:1151–1157. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang CY, Hua L, Sun J, Yao KH, Chen JT,
Zhang JJ and Hu JH: MiR-211 inhibits cell proliferation and
invasion of gastric cancer by down-regulating SOX4. Int J Clin Exp
Pathol. 8:14013–14020. 2015.PubMed/NCBI
|
|
39
|
Yu Z, Ni L, Chen D, Zhang Q, Su Z, Wang Y,
Yu W, Wu X, Ye J, Yang S, et al: Identification of miR-7 as an
oncogene in renal cell carcinoma. J Mol Histol. 44:669–677. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shen A, Zhang Y, Yang H, Xu R and Huang G:
Overexpression of ZEB1 relates to metastasis and invasion in
osteosarcoma. J Surg Oncol. 105:830–834. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Singh M, Spoelstra NS, Jean A, Howe E,
Torkko KC, Clark HR, Darling DS, Shroyer KR, Horwitz KB, Broaddus
RR and Richer JK: ZEB1 expression in type I vs type II endometrial
cancers: A marker of aggressive disease. Mod Pathol. 21:912–923.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Graham TR, Zhau HE, Odero-Marah VA,
Osunkoya AO, Kimbro KS, Tighiouart M, Liu T, Simons JW and O'Regan
RM: Insulin-like growth factor-I-dependent up-regulation of ZEB1
drives epithelial-to-mesenchymal transition in human prostate
cancer cells. Cancer Res. 68:2479–2488. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Drake JM, Strohbehn G, Bair TB, Moreland
JG and Henry MD: ZEB1 enhances transendothelial migration and
represses the epithelial phenotype of prostate cancer cells. Mol
Biol Cell. 20:2207–2217. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hurt EM, Saykally JN, Anose BM, Kalli KR
and Sanders MM: Expression of the ZEB1 (deltaEF1) transcription
factor in human: Additional insights. Mol Cell Biochem. 318:89–99.
2008. View Article : Google Scholar : PubMed/NCBI
|
